QA: Greenwich Lifesciences Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001799788_2024_Greenwich_Lifesciences_Inc.pdf

Logs

Graph

Absolute values for 0001799788, Greenwich Lifesciences Inc

  xvar xval
0 AssetsCurrent 0
1 IntangibleAssetsNetIncludingGoodwill 5,391
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 6,989,424
4 LiabilitiesCurrent 294,406
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 1,663,907
9 ResearchAndDevelopmentExpense 11,560,442
10 remainder_Expenses 0
11 remainder_Revenues 0
12 remainder_NetIncome 1,539,756
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 6,994,815
1 Liabilities 294,406
2 Expenses 13,224,349
3 Revenues 0
4 StockholdersEquity 6,700,409
5 NetIncome -11,684,593
6 ComprehensiveNetIncome -11,684,593
7 BaseVar 11,026,663
8 EconomicCapitalRatiobeforeLimitedLiability 0.802
9 EconomicCapitalRatio 2.14

Edgar->Model Mapping

Feature Distribution

Change over Time